Skip to main content

Modelling Clinical Decay Data Using Exponential Functions

  • Conference paper
  • First Online:
Approximation Algorithms for Complex Systems

Part of the book series: Springer Proceedings in Mathematics ((PROM,volume 3))

Summary

Monitoring of a cancer patient, following initial administration of a drug, provides a time sequence of measured response values constituting the level in serum of the relevant enzyme activity. The ability to model such clinical data in a rigorous way leads to (a) an improved understanding of the biological processes involved in drug uptake, (b) a measure of total absorbed dose, and (c) a prediction of the optimal time for a further stage of drug administration. A class of mathematical decay functions is studied for modelling such activity data, taking into account measurement uncertainties associated with the response values. Expressions for the uncertainties associated with the biological processes in (a) and with (b) and (c) are obtained. Applications of the model to clinical data from two hospitals are given.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. BIPM, IEC, IFCC, ILAC, ISO, IUPAC, IUPAP, and OIML. Evaluation of measurement data — guide to the expression of uncertainty in measurement. Joint Committee for Guides in Metrology, JCGM 100:2008. http://www.bipm.org/utils/common/documents/jcgm/JCGM1002008E.pdf.

  2. BIPM, IEC, IFCC, ILAC, ISO, IUPAC, IUPAP, and OIML. Evaluation of measurement data — supplement 1 to the “Guide to the expression of uncertainty in measurement” — propagation of distributions using a Monte Carlo method. Joint Committee for Guides in Metrology, JCGM 101:2008. http://www.bipm.org/utils/common/documents/jcgm/JCGM1012008E.pdf.

  3. M.G. Cox: The evaluation of key comparison data. Metrologia 39, 2002, 589–595.

    Article  Google Scholar 

  4. M.G. Cox and P.M. Harris: SSfM Best Practice Guide No. 6, Uncertainty Evaluation. Technical Report DEM-ES-011, National Physical Laboratory, Teddington, UK, 2006. http://publications.npl.co.uk/nplweb/pdf/demes11.pdf.

  5. A. Divoli, A. Spinelli, S. Chittenden, D. Dearnaley, and G. Flux: Whole-body dosimetry for targeted radionuclide therapy using spectral analysis. Cancer Biol. Radiopharm. 20, 2005, 66–71.

    Article  Google Scholar 

  6. C. Elster: Calculation of uncertainty in the presence of prior knowledge. Metrologia 44, 2007, 111–116.

    Article  Google Scholar 

  7. G.D. Flux, M.J. Guy, R. Beddows, M. Pryor, and M.A. Flower: Estimation and implications of random errors in whole-body dosimetry for targeted radionuclide therapy. Phys. Med. Biol. 47, 2002, 3211–3223.

    Article  Google Scholar 

  8. R. Francis and R.H.J. Begent: Monoclonal antibody targeting therapy: an overview. In Targeted Therapy for Cancer K. Syrigos and K. Harrington (eds.), Oxford University Press, Oxford, 2003, 29–46.

    Google Scholar 

  9. G. Golub and V. Pereyra: Separable nonlinear least squares: the variable projection method and its applications. Inverse Problems 19, 2003, R1–R26.

    Article  MATH  MathSciNet  Google Scholar 

  10. C. Hindorf, S. Chittenden, L. Causer, V.J. Lewington, and H. M¨acke: Dosimetry for 90Y-DOTATOC therapies in patients with neuroendocrine tumors. Cancer Biol. Radiopharm. 22, 2007, 130–135.

    Google Scholar 

  11. IUPAC compendium of chemical terminology. http://goldbook.iupac.org/B00658.html.

  12. E.T. Jaynes:Where do we stand on maximum entropy? In Papers on Probability, Statistics, and Statistical Physics, R.D. Rosenkrantz (ed.), Kluwer Academic, Dordrecht, The Netherlands, 1989, 210–314.

    Google Scholar 

  13. A. Mayer, R.J. Francis, S.K. Sharma, B. Tolner, C.J.S. Springer, J. Martin, G.M. Boxer, J. Bell, A.J. Green, J.A. Hartley, C. Cruickshank, J. Wren, K.A. Chester, and R.H.J. Begent: A phase I study of single administration of antibody-directed enzyme prodrug therapy with the recombinant anticarcinoembryonic antigen antibody-enzyme fusion protein MFECP1 and a bisiodo

    Google Scholar 

  14. phenol mustard prodrug. Clin. Cancer Res. 12, 2006, 6509–6516.

    Google Scholar 

  15. M.G. Stabin and J.A. Siegel: Physical models and dose factors for use in internal dose assessment. Health Phys. 85, 2003, 294.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Cox, M.G. (2011). Modelling Clinical Decay Data Using Exponential Functions. In: Georgoulis, E., Iske, A., Levesley, J. (eds) Approximation Algorithms for Complex Systems. Springer Proceedings in Mathematics, vol 3. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-16876-5_8

Download citation

Publish with us

Policies and ethics